<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Anticancer Efficacy and Mechanisms of a Dual Targeting of Norepinephrine Transporter and Thyrointegrin αvβ3 Antagonist in Neuroblastoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Anticancer Efficacy and Mechanisms of a Dual Targeting of Norepinephrine Transporter and Thyrointegrin αvβ3 Antagonist in Neuroblastoma." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7086/9174855/d4dd6f8d5a01/jcav13p2594g003.jpg"/> </div> <div class="text-side"> <h1>Anticancer Efficacy and Mechanisms of a Dual Targeting of Norepinephrine Transporter and Thyrointegrin αvβ3 Antagonist in Neuroblastoma.</h1> <p>Histopathological images of H&amp;E staining of xenografts after 21 days of treatment with control (PBS) and BG-P400-TAT (10 mg/kg) in SCID and NSG mice. The scale bar is 10X. Complete infiltration (~100%) with the malignant cells was observed in controls. In treatment groups, necrosis, and hyalinization &gt;90% were observed. Green arrows indicate fibroblasts, black arrow indicates blood vessels with red blood cells.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35711848/" target="_blank">35711848</a></p><p>Type: Premalignant/Malignant, Category: Neural or neuroendocrine</p>
</div> </div></div></body></html>